Screening, Confirmation, and Quantification Serve Different Purposes

Overview

Short answer: the analytical stage determines what you can reasonably claim about a sample — screening provides preliminary class-level indications, confirmatory identification supports specific substance identity, and quantitative analysis estimates how much is present; each stage uses different methods and carries different limits on the strength of inference .

Why this matters: when reading reports, news, or research that cite laboratory results, the stated method and analytical stage shape what conclusions are supported. Health Canada’s Drug Analysis Service (DAS) distinguishes "screening" from "confirmatory identification" and treats quantification as a separate, less widely available service; these terms mark different evidentiary weights and types of uncertainty .

How the stages differ

Screening — class-level, rapid, provisional

Confirmatory identification — specific identity, higher confidence

Quantification — how much, with additional constraints

How to read claims in practice — an evidence-focused approach

What remains unresolved without primary method documentation

Summary Screening, confirmatory identification, and quantification are complementary but distinct stages: screening gives provisional class-level signals; confirmatory analysis supports specific identity; quantification estimates amount but brings its own uncertainty. Good evidence use requires checking which stage produced a result, reviewing method details and limitations, and treating claims in proportion to the analytical stage and the documented constraints .

• Purpose: Screening is designed to detect the possible presence of classes of drugs or characteristic chemical features. It is useful for triage, surveillance, or prioritizing samples for further analysis.
• Typical methods: Rapid techniques that produce patterns or signals consistent with a substance class (for example, immunoassays, some forms of spectrometry used in a preliminary mode, or spot/color tests).
• Strength of claim: Results are provisional. A positive screening result supports the statement "this sample tested positive for a substance characteristic of X class" but not the definitive statement "this sample contains compound Y." False positives and cross-reactivity can occur; therefore screening cannot by itself establish specific identity .
• Evidentiary use: Screening can justify further testing, indicate trends in surveillance data, or inform immediate risk-avoidance measures when time is critical — but it should be presented as preliminary, with clear limits on specificity .
• Purpose: Confirmatory identification aims to determine the specific chemical identity of an analyte in a sample, using methods that meet established criteria for selectivity and reproducibility.
• Typical methods: Techniques such as mass spectrometry with appropriate separation (e.g., GC–MS, LC–MS/MS) and reference comparisons are commonly used for confirmatory work. These methods generate data that can be compared with authenticated standards and characteristic spectra to support a specific identification.
• Strength of claim: When performed according to appropriate guidelines, confirmatory methods support stronger claims such as "compound Y was identified in the sample." However, the strength depends on method parameters: how many identifying features match the reference, instrument settings, and the availability of reference standards. Even confirmatory results are limited by the method’s validated scope (sample types, concentration ranges, interferences) and by the chain of custody and documentation for the specific sample .
• Evidentiary use: Confirmatory identification is the appropriate basis for statements about which chemical species are present. It is the level needed for many scientific, regulatory, and forensic conclusions — but readers should check whether the report specifies which confirmatory criteria were met and whether those criteria are applicable to the sample matrix .
• Purpose: Quantitative analysis estimates the concentration or mass of an identified substance in a sample.
• Typical methods: Quantification usually uses calibrated instrumental techniques (e.g., quantitative LC–MS/MS) with validated calibration curves, internal standards, and controls.
• Strength of claim: A numerical concentration conveys more detailed information but also introduces additional sources of uncertainty: matrix effects, extraction efficiency, calibration range, limits of quantification, and method reproducibility. Health Canada’s DAS notes that quantitative services are not always available and that quantitation may be performed only when method suitability for the sample matrix and the client’s needs are established .
• Evidentiary use: Quantitative data can support dose-related discussions, prevalence metrics, and exposure assessment — but only when accompanied by method-specific uncertainty estimates and documentation of how the numbers were derived. Without such documentation, numerical values should be treated as approximate and conditional .
• Check what analytical stage is reported. Is the result described as a screening finding, a confirmatory identification, or a quantitative measurement? The wording matters because it signals the intended evidential strength .
• Look for method details tied to the claim. For confirmatory and quantitative claims, credible reporting will state or reference analytical techniques and the criteria used for identification or quantification (e.g., number of ions matched, calibration approach). Absence of this detail reduces the claim’s verifiability.
• Ask about scope and limitations. Even a confirmatory method does not prove universal fitness: whether the method is validated for the particular matrix (powder, liquid, biological sample), concentration range, or interfering substances must be stated. Health Canada explicitly documents data sources and limitations that affect interpretation of DAS results; readers should expect analogous caveats in any lab report .
• Treat numerical results as conditional without uncertainty metrics. Quantities are meaningful only with limits of detection, limits of quantification, recovery rates, and confidence intervals or similar measures. If those are missing, treat numbers as provisional estimates .
• Distinguish population-level inference from single-sample claims. A single confirmatory identification supports presence in that sample; it does not automatically establish wider prevalence or typical potency without representative sampling and appropriate quantitative data.
• Whether a particular analytical procedure was validated for the exact matrix and concentration range in your sample.
• The measurement uncertainty and bias associated with reported concentrations.
• The number and nature of identifying criteria met in a confirmatory identification (for example, which spectral features or ions matched reference standards).